Verition Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
64,800
+3,100
+5% +$81.1K 0.01% 1222
2026
Q1
$1.73M Buy
61,700
+13,500
+28% +$359K 0.01% 1090
2025
Q4
$1.2M Sell
48,200
-33,100
-41% -$835K ﹤0.01% 2010
2025
Q3
$2.07M Buy
81,300
+60,400
+289% +$1.49M 0.01% 1947
2025
Q2
$507K Buy
+20,900
New +$487K ﹤0.01% 2934
2024
Q3
Sell
-16,200
Closed -$453K 3445
2024
Q2
$453K Buy
+16,200
New +$446K ﹤0.01% 2101
2024
Q1
Sell
-17,300
Closed -$498K 2929
2023
Q4
$498K Hold
17,300
﹤0.01% 1520
2023
Q3
$574K Buy
+17,300
New +$612K 0.01% 1363
2022
Q2
Sell
-9,200
Closed -$476K 2890
2022
Q1
$476K Buy
+9,200
New +$477K 0.01% 1928
2021
Q1
Sell
-69,900
Closed -$2.57M 1719
2020
Q4
$2.57M Buy
+69,900
New +$2.56M 0.02% 325

Other funds holding PFE

Verition Fund Management's PFE Position: Q2 2026 in Review

Verition Fund Management opened a new position in Pfizer (PFE) in Q2 2026: 58,607 shares worth $1.41M. The stake represents 0.01% of the portfolio and ranks #1280 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in PFE as recently as Q4 2025.

Verition Fund Management first reported a position in PFE in Q3 2013 and has held it in 38 quarters since. The position peaked at $9.32M in Q3 2025. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Verition Fund Management held 58,607 shares of Pfizer worth $1.41M as of Q2 2026.
  • Pfizer was a new Verition Fund Management position in Q2 2026.
  • Pfizer made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1280 holding.
  • Verition Fund Management first reported a position in Pfizer in Q3 2013 and has held it in 38 quarters since.
  • Verition Fund Management's Pfizer position peaked at $9.32M in Q3 2025.
  • 2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.